Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

CV Sciences (CVSI) EPS (Weighted Average and Diluted) (2017 - 2025)

CV Sciences' EPS (Weighted Average and Diluted) history spans 9 years, with the latest figure at -$0.0 for Q3 2025.

  • For Q3 2025, EPS (Weighted Average and Diluted) rose 21.5% year-over-year to -$0.0; the TTM value through Sep 2025 reached -$0.01, up 18.97%, while the annual FY2024 figure was -$0.01, 150.0% down from the prior year.
  • EPS (Weighted Average and Diluted) for Q3 2025 was -$0.0 at CV Sciences, down from -$0.0 in the prior quarter.
  • Across five years, EPS (Weighted Average and Diluted) topped out at $0.04 in Q1 2023 and bottomed at -$0.08 in Q4 2021.
  • The 5-year median for EPS (Weighted Average and Diluted) is -$0.01 (2024), against an average of -$0.01.
  • The largest annual shift saw EPS (Weighted Average and Diluted) plummeted 1783.9% in 2022 before it surged 300.0% in 2023.
  • A 5-year view of EPS (Weighted Average and Diluted) shows it stood at -$0.08 in 2021, then soared by 75.0% to -$0.02 in 2022, then skyrocketed by 50.0% to -$0.01 in 2023, then soared by 73.59% to -$0.0 in 2024, then increased by 21.5% to -$0.0 in 2025.
  • Per Business Quant, the three most recent readings for CVSI's EPS (Weighted Average and Diluted) are -$0.0 (Q3 2025), -$0.0 (Q2 2025), and -$0.0 (Q1 2025).